1-Ethynylpyrene
(Synonyms: 1-乙炔基芘) 目录号 : GC604461-Ethynylpyrene是细胞色素P4501A1,1A2和2B1的抑制剂,IC50分别为0.18,0.32和0.04μM。
Cas No.:34993-56-1
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
1-Ethynylpyrene is an aryl acetylenic inhibitor of cytochromes P450 1A1, 1A2, and 2B1 with IC50s of 0.18, 0.32, and 0.04 μM, respectively[1].
1-Ethynylpyrene exhibits activity against P450 1A2, and 2B1 with Kis of 0.32 and 0.04 μM, respectively[1].
[1]. Naijue Zhu, et al. Ethynyl and Propynylpyrene Inhibitors of Cytochrome P450. J Chem Crystallogr. 2010 Apr 1;40(4):343-352.
Cas No. | 34993-56-1 | SDF | |
别名 | 1-乙炔基芘 | ||
Canonical SMILES | C#CC1=C(C2=C34)C=CC4=CC=CC3=CC=C2C=C1 | ||
分子式 | C18H10 | 分子量 | 226.27 |
溶解度 | 储存条件 | Store at -20°C | |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 4.4195 mL | 22.0975 mL | 44.195 mL |
5 mM | 0.8839 mL | 4.4195 mL | 8.839 mL |
10 mM | 0.4419 mL | 2.2097 mL | 4.4195 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
2-(1-Ethynylpyrene)-adenosine as a folding probe for RNA - pyrene in or out
Chembiochem 2010 Mar 22;11(5):664-72.PMID:20183842DOI:10.1002/cbic.200900778.
A series of short RNA duplexes containing one or two 1-ethynylpyrene-modified adenine bases was synthesised. The melting behaviour of these duplexes was examined by monitoring temperature-dependent pyrene fluorescence. In the singly modified RNA duplexes, the bases flanking the ethynylpyrene-rA were varied to examine the sequence specificity of the fluorescence change of pyrene upon RNA hybridisation. Because an increase in pyrene fluorescence upon melting of the duplex can be correlated with intercalation of pyrene, and a decrease is usually associated with the position of pyrene outside the strand, a relationship between the flanking bases and the tendency of the dye to intercalate has been established. It was found that pyrene intercalation is less likely to take place if the modified base is flanked only by A-U base pairs. Flanking G-C base pairs, even only in the 5'-direction of the modified base, will favour intercalation. In addition, we examined a doubly modified compound that had a pyrene located on each strand. The spectra indicated that the two pyrenes were close enough for interaction. Upon melting of the strand, a fluorescence blue shift corresponding to the dissociation of the pyrene-pyrene complex could be observed in addition to the intensity effect already known from the singly modified compounds. Two melting curves based on the different properties of the fluorophore could be extracted, leading to different melting points corresponding to the global duplex melting and to the change of local pyrene environment, respectively.
1-ethynylpyrene-modified guanine and cytosine as optical labels for DNA hybridization
Org Biomol Chem 2005 Jun 7;3(11):2062-3.PMID:15917887DOI:10.1039/b504079e.
1-Ethynylpyrene shows remarkable absorption changes upon DNA hybridization when it is covalently attached to the 8-position of guanine. An absorption band at approximately 420 nm is only present in the duplex, exhibits thermal melting behaviour and provides the basis for a molecular beacon together with 1-ethynylpyrene-modified cytosine.
Photo-physical properties of 2-(1-Ethynylpyrene)-adenosine: influence of hydrogen bonding on excited state properties
Phys Chem Chem Phys 2014 Jul 21;16(27):13875-88.PMID:24894337DOI:10.1039/c4cp01148a.
The photo-physical properties of 2-(1-Ethynylpyrene)-adenosine (PyA), a fluorescent probe for RNA dynamics, were examined by solvation studies. The excited-state dynamics display the influence of the vicinity on the spectral features. Combining improved transient absorption and streak camera measurements along with a new analysis method provide a detailed molecular picture of the photophysics. After intramolecular vibrational energy redistribution (IVR), two distinct states are observed. Solvent class (protic/aprotic) and permittivity strongly affect the properties of these states and their population ratio. As a result their emission spectrum is altered, while the fluorescence quantum yield and the overall lifetime remain nearly unchanged. Consequently, the hitherto existing model of the photophysics is herein refined and extended. The findings can serve as basis for improving the information content of measurements with PyA as a label in RNA.
1-Ethynylpyrene, a suicide inhibitor of cytochrome P-450 dependent benzo[a]pyrene hydroxylase activity in liver microsomes
Biochemistry 1984 Aug 14;23(17):3827-36.PMID:6487578DOI:10.1021/bi00312a006.
The preparation of 1-Ethynylpyrene (EP) is described. Incubation of EP with liver microsomes in the presence of NADPH yields fluorescent products, but the production of these products ceases after 15 min. Addition of fresh microsomes restores the original rate of EP metabolism. The metabolism of EP is initially more rapid in microsomes from 5,6-benzoflavone- (BF) pretreated rats than in microsomes from phenobarbital- (PB) pretreated rats or from untreated, control animals. EP strongly inhibits the hydroxylation of benzo[a]pyrene (BP) by liver microsomes; after 20 min in the presence of EP, BP metabolism nearly ceases. Addition of fresh microsomes restores the original rate of BP hydroxylation. EP more effectively inhibits the oxidation of BP in liver microsomes from rats pretreated with BF than from rats pretreated with PB or from untreated, control animals. The inhibition of BP hydroxylation activity due to EP is dependent upon NADPH and is apparently irreversible. Kinetic analyses demonstrate that the observed inhibition of BP hydroxylation is due to loss of the enzymatic activity by a process that is first order in EP and that reaches a limiting value at infinite EP concentrations. One such first-order process, with a t 1/2 of 3.5 min and a Ks for EP of 40 microM, is observed in microsomes from BF-pretreated rats. Two such first-order processes, one with t 1/2 of 6.9 min and Ks of 46 microM and one with t 1/2 of 12.7 min and Ks of 33 microM, are observed in microsomes from PB-pretreated rats. It is proposed that a self-catalyzed inhibition (suicide inhibition) of the cytochrome P-450 dependent BP hydroxylation occurs in the presence of EP. Incubation with EP under conditions that result in loss of about 90% of the BP hydroxylase activity in microsomes from BF-pretreated rats and about 66% of the activity in microsomes from PB-pretreated rats causes the loss of only 6 and 12% of the cytochrome P-450, respectively. It is concluded that loss of P-450 content is an insensitive measure of the effect of this inhibitor upon this cytochrome P-450 dependent enzyme activity. The selectivity of the loss of P-450 due to the incubation of the different microsomal preparations with EP is also observed to be different than the selectivity for loss of BP hydroxylase activity. It is proposed that the suicide inhibition of cytochrome P-450 dependent enzymes by alkynes need not involve heme alkylation and a resulting loss of P-450 content.(ABSTRACT TRUNCATED AT 400 WORDS)
Determinants of protein modification versus heme alkylation: inactivation of cytochrome P450 1A1 by 1-Ethynylpyrene and phenylacetylene
Chem Res Toxicol 1993 Jan-Feb;6(1):38-45.PMID:8448348DOI:10.1021/tx00031a006.
Reaction of cytochrome P450 enzymes with arylacetylenes results in heme N-alkylation [e.g., Komives, E. A., and Ortiz de Montellano, P. R., (1985) J. Biol. Chem. 260, 3330-3336] and/or protein modification [e.g., Gan, L.-S. L., Acebo, A. L. and Alworth, W. L. (1984) Biochemistry 23, 3827-3836]. To clarify the factors that determine whether heme or protein alkylation occurs, we have investigated the cytochrome P450 1A1-catalyzed oxidation of 1-Ethynylpyrene (1-EP) and phenylacetylene (PA). Cytochrome P450 1A1 in microsomes from beta-naphthoflavone-induced rats is inactivated in a time- and NADPH-dependent manner by 1-EP and PA. Parallel loss of the heme chromophore is observed with PA but not with 1-EP, although partial heme chromophore loss is observed when the purified, reconstituted enzyme is inactivated by either agent. Product analysis shows that 1-EP and PA are oxidized to, respectively, (1'-pyrenyl)-acetic and phenylacetic acids. In contrast to the inactivation of cytochrome P450 2B1 by PA, no isotope effect is observed on enzyme inactivation or metabolite formation when the acetylenic hydrogen is replaced by deuterium in either 1-EP or PA. Inactivation of cytochrome P450 1A1 by 1-EP results in covalent binding of 0.8-0.9 equiv (relative to total cytochrome P450 content) of the inhibitor to the microsomal protein. The results demonstrate that a single isozyme can be inactivated, depending on the structure of the arylacetylene, by heme or protein alkylation. Spectroscopic binding constants (Ks) show that 1-EP binds to the enzyme with > 2000 times greater affinity that PA.(ABSTRACT TRUNCATED AT 250 WORDS)